Time: 13:20-16:30, July 28, 2023 (Friday)
Venue: Conference room 500, 5F Taipei Nangang International Exhibition Center, Hall1 (On-site)
Fee: Free of charge
On-line registration: Click here (Accept on-site registration)
| Time | Subject | Speakers |
| 13:20~13:25 | Opening remarks | NHRI
Wei J. Chen, Vice President |
| 13:25~13:30 | Brief of the agenda
Procedures for industry-academia collaboration Procedures for technology transfer |
Hua-hsuan Liang (TTIC)
Tsui-hui Wu (TTIC) |
| 13:30~13:40 | Precision epidemic prevention: Targeted antigen | National Institute of Infectious Diseases and Vaccinology (NIIDV)
Hsin-Wei Chen, Deputy Director |
| 13:40~13:50 | Precision epidemic prevention: Mucosal adjuvant | |
| 13:50~14:00 | Precision epidemic prevention: Assembly teaching aid in immunology | Immunology Research Center
Yu-wen Su, Associate PI |
| 14:00~14:10 | Precision medicine: A Novel broad spectrum cancer immunotherapeutic agent targeting CD47-SIRPα “Don’t eat me” signaling axis | Institute of Biotechnology and Pharmaceutical Research (IBPR)
Wan-Ching Yen, Senior PI |
| 14:10~14:20 | Precision medicine: Discovery of a novel antibody-drug conjugate (ADC) for the potential treatment of cancer cells expressing neurotensin receptor 1 (NTSR1) | Yueh Andrew Yueh, Senior PI (IBPR) |
| 14:20~14:30 | Precision medicine: A novel small-molecule neuroprotective drug for preventing chemotherapy-induced peripheral neuropathy | Yi-Fan Chen, Postdoctoral Researcher (IBPR) |
| 14:30~14:40 | Precision health care: A new method to enhance the safety of ketamine in treating depression | Center for Neuropsychiatric Research
Hwei-Hsien Chen, Senior PI |
| 14:40~14:50 | Introduction of Taiwan Universe Biomedicine (Tai-U, a NHRI start-up company) | Min-Shi Lee, Senior PI (NIIDV) |
| 14:50～15:00 | DEEP01 LIMITED
DeepCT – World-leading AI-based Brain CT Clinical Decision Support System |
David Chou |
| 15:00～15:10 | LuminX Biotech Co.,Ltd
The Reincarnation of Cells – Cellular Tracking for Therapy Impact Analysis |
Dr. Harry Su, Founder & CEO |
| 15:10～15:20 | Acura Nanomedicine Inc.
Multi-Target Anti-Cancer Strategy of AN-845 & Advanced Nano-Delivery Vehicle Platforms of Acura NanoMedicine |
Brian Hsu |
| 15:20～15:30 | EPISONICA CORPORATION
Next Generation MRgHIFU – ArcBlate System |
Dr. Kai Chang, Medical Director at EpiSonica |
| 15:30～15:40 | Jubilee International Biomedical Co., Ltd.
Revolutionary Technology in Healthcare and Beauty – Low-Temperature Cold Plasma |
Liu Chih Tung / CTO |
| 15:40～15:50 | EXONOX BIOSCIENCES, INC.
Exosome-Based Liquid Biopsy for Differential Diagnosis of Triple-Negative Breast Cancer |
Weicheng Su / Chief Operating Officer |
| 15:50～16:00 | Taiwan Genomic Industry Alliance Inc.
Unraveling the Human Genome: Comprehensive Profiling through NovaSeq X Sequencing and Advanced TGIA Analysis Techniques. |
Dr. Lin, Chien-Hsing Ph.D.
TGIA Inc. CTO |
| 16:00～16:10 | BioLASCO Taiwan Co., Ltd.
From experimental animals to animal experiments solutions |
Hank Chen, the President of BioLASCO Taiwan Co., Ltd. |
| 16:10～16:20 | ITAMINS
Strategic Biomedical Marketing |
Tzu-Hua Weng, MD/Ph.D.
Justine Yang, CEO |
| 16:20～16:30 | Taiwan Web Service Corporation
OneAI – High performance computing and biomedical AI generate new value for precision medicine |
Jamie Chang / Product Manager |
Contact us: Technology Transfer & Incubation Center, NHRI
Ms. Tsui-hui Wu or Mr. Richard Yeh at 886+ 37-206166 ext.33202 or 33212
【Organizer】National Health Research Institutes
【Co-organizer】Taiwan Web Service Corporation (TWS)
【Sponsor】Ministry of Health and Welfare
Small and Medium Enterprise Administration, MOEA
